Characterization of recombinant hERG K(+) channel inhibition by the active metabolite of amiodarone desethyl-amiodarone.

[1]  J. Hancox,et al.  Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2]  Martin Borggrefe,et al.  Short QT syndrome. Update on a recent entity. , 2008, Archives of cardiovascular diseases.

[3]  J. Hancox,et al.  Pharmacology of the short QT syndrome N588K‐hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs , 2008, British journal of pharmacology.

[4]  S. Krähenbühl,et al.  Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues , 2008, British journal of pharmacology.

[5]  Jules C Hancox,et al.  The hERG potassium channel and hERG screening for drug-induced torsades de pointes. , 2008, Pharmacology & therapeutics.

[6]  Martyn P Mahaut-Smith,et al.  Temperature dependence of human ether-a-go-go-related gene K+ currents. , 2006, American journal of physiology. Cell physiology.

[7]  M. Sanguinetti,et al.  hERG potassium channels and cardiac arrhythmia , 2006, Nature.

[8]  Jules C Hancox,et al.  High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656. , 2004, Biochemical and biophysical research communications.

[9]  J. Hancox,et al.  Lidoflazine is a high affinity blocker of the HERG K(+)channel. , 2004, Journal of molecular and cellular cardiology.

[10]  J. Tamargo,et al.  Pharmacology of Cardiac Potassium Channels , 2003 .

[11]  W. Crumb,et al.  Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels. , 2004, Journal of pharmacological sciences.

[12]  Martin Borggrefe,et al.  Short QT Syndrome: A Familial Cause of Sudden Death , 2003, Circulation.

[13]  D. Roden,et al.  Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias , 2001, Journal of cardiovascular pharmacology.

[14]  S. Doggrell.  Amiodarone - waxed and waned and waxed again , 2001, Expert opinion on pharmacotherapy.

[15]  Itsuo Kodama,et al.  Short- and Long-Term Effects of Amiodarone on the Two Components of Cardiac Delayed Rectifier K+ Current , 2001, Circulation.

[16]  A. Bennett,et al.  Anti-inflammatory drugs, cyclooxygenases and other factors , 2001, Expert opinion on pharmacotherapy.

[17]  W. Kübler,et al.  Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  Harry J. Witchel,et al.  Time course and voltage dependence of expressed HERG current compared with native ”rapid” delayed rectifier K current during the cardiac ventricular action potential , 1998, Pflügers Archiv.

[19]  K. Kamiya,et al.  Cellular electropharmacology of amiodarone. , 1997, Cardiovascular research.

[20]  J. Papp,et al.  Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes , 1996, British journal of pharmacology.

[21]  K. Kamiya,et al.  Electrophysiologic effects of desethylamiodarone, an active metabolite of amiodarone: comparison with amiodarone during chronic administration in rabbits. , 1988, American heart journal.

[22]  G. Jablonsky,et al.  Prophylaxis of post-myocardial infarction dysrhythmias by long-term timolol therapy. , 1988, American heart journal.

[23]  S. Nattel,et al.  The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. , 1988, Circulation.

[24]  R. Phair,et al.  Electropharmacology of amiodarone: absence of relationship to serum, myocardial, and cardiac sarcolemmal membrane drug concentrations. , 1986, American heart journal.

[25]  S. Yabek,et al.  Effects of Amiodarone and its Metabolite, Desethylamiodarone, on the Electrophysiologic Properties of Isolated Cardiac Muscle , 1986, Journal of cardiovascular pharmacology.

[26]  K. Nademanee,et al.  Amiodarone kinetics after oral doses , 1982, Clinical pharmacology and therapeutics.